GlassScriptPhysician profile
Devesh Ramnath
NPI 1871580621
$5,177.41
in general payments reported to CMS, 2019-2025
13 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,873 · 2020: $68.52 · 2021: $70.32 · 2022: $477 · 2023: $218 · 2024: $302 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovasis INC | $2,473.74 | 2019-2023 | |
| Medical Device Business Services, INC. | $1,444.62 | 2019 | |
| Depuy Synthes Sales INC. | $332.32 | 2019-2024 | X-Pac |
| Orthofix Medical, INC. | $285.12 | 2021-2024 | Mariner Deformity |
| Abbott Laboratories | $241.10 | 2022-2025 | Proclaim |
| Horizon Therapeutics Plc | $114.30 | 2019-2022 | |
| Medtronic, INC. | $101.20 | 2022-2023 | Catalyft Pl Expandable Interbody System |
| Globus Medical, INC. | $78.85 | 2021-2024 | Modulus, Caliber, Reline |
| Si-Bone, INC. | $38.00 | 2020 | |
| Stryker Corporation | $24.11 | 2022 | |
| Ethicon US, LLC | $15.82 | 2024 | Surgiflo Hemostatic Matrix |
| Pacira Pharmaceuticals Incorporated | $14.39 | 2022 | |
| Bioventus LLC | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devesh Ramnath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.